BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34439783)

  • 1. Why Is Aneuploidy Associated with Favorable Outcome in Neuroblastoma?
    Tonini GP
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Do Telomere Abnormalities Regulate the Biology of Neuroblastoma?
    Akter J; Kamijo T
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth, progression and chromosome instability of Neuroblastoma: a new scenario of tumorigenesis?
    Tonini GP
    BMC Cancer; 2017 Jan; 17(1):20. PubMed ID: 28056863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulated NORAD in neuroblastoma promotes cell proliferation via chromosomal instability and predicts poor prognosis.
    Yu Y; Chen F; Jin Y; Yang Y; Wang S; Zhang J; Chen C; Zeng Q; Han W; Wang H; Guo Y; Ni X
    Acta Biochim Pol; 2020 Dec; 67(4):595-603. PubMed ID: 33326736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aneuploidy in neuroblastoma tumors is not associated with inactivating point mutations in the STAG2 gene.
    Djos A; Fransson S; Kogner P; Martinsson T
    BMC Med Genet; 2013 Oct; 14():102. PubMed ID: 24088605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumour diversity of chromosome copy numbers in neuroblastoma mediated by on-going chromosome loss from a polyploid state.
    Lundberg G; Jin Y; Sehic D; Øra I; Versteeg R; Gisselsson D
    PLoS One; 2013; 8(3):e59268. PubMed ID: 23555645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD133 expression and MYCN amplification induce chemoresistance and reduce average survival time in pediatric neuroblastoma.
    Zhong ZY; Shi BJ; Zhou H; Wang WB
    J Int Med Res; 2018 Mar; 46(3):1209-1220. PubMed ID: 29322842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelic imbalance on chromosome 5q predicts long-term survival in neuroblastoma.
    Meltzer SJ; O'Doherty SP; Frantz CN; Smolinski K; Yin J; Cantor AB; Liu J; Valentine M; Brodeur GM; Berg PE
    Br J Cancer; 1996 Dec; 74(12):1855-61. PubMed ID: 8980382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two cases of localized neuroblastoma with multiple segmental chromosomal alterations and metastatic progression.
    Morales La Madrid A; Nall MB; Ouyang K; Minor A; Raca G; Kent P; Miller I; Schleiermacher G; Janoueix-Lerosey I; Cohn SL
    Pediatr Blood Cancer; 2013 Feb; 60(2):332-5. PubMed ID: 22997192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative genomic hybridization reveals changes in DNA-copy number in poor-risk neuroblastoma.
    Vettenranta K; Aalto Y; Wikström S; Knuutila S; Saarinen-Pihkala U
    Cancer Genet Cytogenet; 2001 Mar; 125(2):125-30. PubMed ID: 11369055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic predisposition and chromosome instability in neuroblastoma.
    Tonini GP; Capasso M
    Cancer Metastasis Rev; 2020 Mar; 39(1):275-285. PubMed ID: 31927719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes.
    Khan FH; Pandian V; Ramraj S; Natarajan M; Aravindan S; Herman TS; Aravindan N
    BMC Cancer; 2015 Jul; 15():514. PubMed ID: 26159519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas.
    Dreidax D; Bannert S; Henrich KO; Schröder C; Bender S; Oakes CC; Lindner S; Schulte JH; Duffy D; Schwarzl T; Saadati M; Ehemann V; Benner A; Pfister S; Fischer M; Westermann F
    Hum Mol Genet; 2014 Dec; 23(25):6826-37. PubMed ID: 25104850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting oncogene expression in a childhood cancer.
    Tuthill MC; Wada RK
    Hawaii Med J; 2003 Oct; 62(10):224-5. PubMed ID: 14631595
    [No Abstract]   [Full Text] [Related]  

  • 15. Chromosome instability in neuroblastoma.
    Fusco P; Esposito MR; Tonini GP
    Oncol Lett; 2018 Dec; 16(6):6887-6894. PubMed ID: 30546420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-mining of copy number profiles of high-risk neuroblastoma tumors.
    Depuydt P; Koster J; Boeva V; Hocking TD; Speleman F; Schleiermacher G; De Preter K
    Sci Data; 2018 Oct; 5():180240. PubMed ID: 30375995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zebrafish as a Neuroblastoma Model: Progress Made, Promise for the Future.
    Li S; Yeo KS; Levee TM; Howe CJ; Her ZP; Zhu S
    Cells; 2021 Mar; 10(3):. PubMed ID: 33800887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of aneuploidy: overcoming the original CIN.
    Storchova Z
    Genes Dev; 2018 Dec; 32(23-24):1459-1460. PubMed ID: 30509947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuron navigator 3 alterations in nervous system tumors associate with tumor malignancy grade and prognosis.
    Carlsson E; Krohn K; Ovaska K; Lindberg P; Häyry V; Maliniemi P; Lintulahti A; Korja M; Kivisaari R; Hussein S; Sarna S; Niiranen K; Hautaniemi S; Haapasalo H; Ranki A
    Genes Chromosomes Cancer; 2013 Feb; 52(2):191-201. PubMed ID: 23097141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric DNA analysis of neuroblastoma: prognostic significance of DNA ploidy in unfavorable group.
    Naito M; Iwafuchi M; Ohsawa Y; Uchiyama M; Hirota M; Matsuda Y; Iinuma Y
    J Pediatr Surg; 1991 Jul; 26(7):834-7. PubMed ID: 1895194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.